The traditional model of biotech entrepreneurship—building full-service companies with discovery, R&D, and marketing under one roof—has proven especially challenging in New York. With wet-lab space scarce and expensive, a dearth of VC funding for early-stage research, and a high cost of living that makes it hard to attract talent, many researchers look elsewhere for entrepreneurial opportunities. But it doesn’t have to be that way. A growing cadre of NYC entrepreneurs are embracing alternative business models that allow them to thrive in the Big Apple. Some are outsourcing everything from basic discovery to development. Others have found funding from disease-oriented foundations, and lab space and office options are growing as well. In this intimate evening forum, we’ll hear from a diverse group of entrepreneurs, venture capitalists, and non-profit leaders who will share valuable insights about everything from recruiting top talent to raising funding—and building a vital life sciences cluster right here in New York.
Confirmed Speakers
- Sam Waksal
- Founder & CEO, Kadmon Pharmaceuticals
- Kevin Kinsella
- Founder & Managing Director, Avalon Ventures
- Jill O’Donnell-Tormey
- CEO and Director of Scientific Affairs, Cancer Research Institute
- Dennis Purcell
- Senior Managing Partner, Aisling Capital
- Arthur Tinkelenberg
- CEO, Enumeral Biomedical
- John Cunningham
- SVP, Regional Market Director, Alexandra Real Estate Equities, Inc.
Follow us on Twitter
@Xconomy
#xcbiobizNY
Schedule
Registration and Networking: 5:30 – 6:30 pm
Program: 6:30 – 7:30 pm
Networking Reception: 7:30 – 8:30 pm
Registration Information
Regular Registration: $150
Startup Special: $75
Student Registration: $30
Walk-in Registration: $175
EVENT PARTNERS
DESIGN SPONSOR
